Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Xiaojin, Wu"'
Autor:
Keya Sha, Xuhui Liu, Peipei Ye, Shanhao Tang, Shuangyue Li, Xian xu Zhuang, Yin Lu, Lieguang Chen, Junjie Cao, Renzhi Pei, Yiyu Xie, Xiaojin Wu, Dong Chen, Xiaohong Du, Pisheng Zhang
Publikováno v:
Leukemia research. 110
In order to investigate the efficacy of lenalidomide, bortezomib and dexamethasone (VRD) induction chemotherapy regimen combined with tandem autologous stem cell transplantation (ASCT) in treating multi-hit multiple myeloma (MM), we analyzed 252 case
Autor:
Jiaqian Qi, Depei Wu, Xiebing Bao, Jia Chen, Hong Liu, Jingjing Han, Yongsheng Li, Huanle Gong, Shuangzhu Liu, Shoubao Ma, Yang Xu, Xiaojin Wu
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Scientific Reports
Scientific Reports
Acute graft-versus-host disease (aGVHD) is a major life-threatening complication after allogeneic haematopoietic stem cell transplantation. Interleukin-27 receptor alpha (IL-27Rα) is a co-receptor of IL-27, an inflammatory cytokine that possesses ex
Autor:
Aining Sun, Yue Han, Xiao Ma, Xiaowen Tang, Guanghua Chen, Chengcheng Fu, Xiaojin Wu, Bin Gu, Depei Wu, Zhengming Jin, Huiying Qiu
Publikováno v:
Leukemia Research. 59:41-46
To investigate the effect of haploidentical allogeneic hematopoietic stem cell transplantation (Haplo-HCT) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), the outcome of 58 patients with Ph+ ALL who received Haplo-HCT (n=4
Publikováno v:
Infection. 48(2)
Stenotrophomonas maltophilia (SM) is an important nosocomial pathogen, particularly in immunocompromised patients due to their adverse antimicrobial susceptibility pattern. The objective of this article was to investigate the clinical impact of SM ba
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology
Frontiers in Immunology
Patients with steroid refractory gastrointestinal (GI) tract graft- vs.-host disease (GvHD) face a poor prognosis and limited therapeutic options. To accurately assess the efficacy and safety of fecal microbiota transplantation (FMT) in treating ster
Autor:
Xiaojing Bao, Yang Li, Huanhuan Zhang, Xiaojin Wu, Xiaoni Yuan, Huifen Zhou, Jun He, Miao Wang, Depei Wu
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:232-239
Donor killer immunoglobulin-like receptor (KIR) group B profiles (Bx) and homozygous of centromeric motif B (Cen-B/B) are the most preferable KIR gene content motifs for hematopoietic stem cell transplantation (HSCT). The risk of transplant from Bx1
Autor:
Depei Wu, Xiaojin Wu, Xiaojing Bao, Huifeng Zhou, Yang Xu, Jia Chen, Xiao Ma, Song Jing, Yao Yao, Hai-Xia Zhou, Bing Gu, Yuejun Liu, Aining Sun, Jun He, Xiaowen Tang, Yue Han
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:220-225
Outcomes for hematopoietic stem cell transplantation (HSCT) in various donor and recipient killer immunoglobulin-like receptor (KIR) genotypes have been studied extensively. The associations between KIR2DS4 and its variant KIR1D with outcomes of HSCT
Publikováno v:
Biology of Blood and Marrow Transplantation. 22(1):86-95
The National Marrow Donor Program and Center for International Blood and Marrow Transplant Research provided guidelines for the use of anti-HLA antibodies and HLA-DP–mismatched loci in unrelated donor hematopoietic stem cell transplantation (HSCT).
Autor:
Bing Yang, Jia Zang, Shuai Wang, Fangfang Zhou, Xiaojin Wu, Li Ling, Long Zhang, Jingxian Li, Feng Chu, Sheng Ye, Z. Zhang, Shixian Lin, Bo Zhang, Aijun Wang, Xiuwu Fang, Huizhe Huang
Publikováno v:
Molecular Cell. 79:304-319.e7
Accurate regulation of innate immunity is necessary for the host to efficiently respond to invading pathogens and avoid excessive harmful immune pathology. Here we identified OTUD3 as an acetylation-dependent deubiquitinase that restricts innate anti
Autor:
Yiyu Xie, Depei Wu, Shoubao Ma, Yuhan Ji, Jianhua Yu, Yue Han, Chang Wang, Xiaojin Wu, Ahmet Yilmaz, Jinge Xu, Xiebing Bao, Jianying Zhang, Bingyu Yang, Suning Chen, Hong Liu
Publikováno v:
JCI Insight. 3
BACKGROUND There are very few studies investigating metabolic biomarkers to predict acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). Metabolic models can provide a framework for analyzing the in